Auxogyn Garners $20,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=61e4f27a-5f82-498c-9b50-18e91d5a6326&Preview=1 - Date
2/2/2012 - Company Name
Auxogyn - Mailing Address
1490 O’Brien Drive Menlo Park, CA 94025 - Company Description
Auxogyn – Advancing women’s reproductive health through novel scientific and clinical knowledge of early human developmental biology. - Website
http://www.auxogyn.com - Transaction Type
Venture Equity - Transaction Amount
$20,000,000 - Transaction Round
Series A - Proceeds Purposes
Over the course of the last year, we have executed an aggressive operating plan in preparation for the commercialization of our first product, Eeva. Importantly, we expect to announce data from our five-site, 150-patient clinical study in the months ahead that will then be used as part of our regulatory filings in Europe and the United States. - M&A Terms
- Venture Investor
Kleiner Perkins Caufield & Byers - Venture Investor
TPG Biotech - Venture Investor
Merck Serono Ventures
